TELA Bio, Inc. (TELA)
NGM – Real vaqt narxi. Valyuta: USD
1.02
+0.05 (5.14%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
1.02
+0.05 (5.14%)
Yopilishda: May 12, 2026, 4:00 PM EDT
TELA Bio, Inc., tijorat bosqichidagi tibbiyot texnologiyalari kompaniyasi, bemorning anatomiyasini saqlash va tiklashga ustunlik berish orqali klinik natijalarni optimallashtiradigan yumshoq to'qimalarni rekonstruksiya qilish echimlarini taqdim etishga qaratilgan. Kompaniya churra va qorin devorini rekonstruksiya qilish uchun OviTex Reinforced Tissue Matrix (OviTex) mahsulotlari portfelini; va plastik va rekonstruktiv jarrohlikdagi dolzarb ehtiyojlarni qondirish uchun OviTex PRS Reinforced Tissue Matrix mahsulotlarini, shuningdek, laparoskopik va robotlashtirilgan muolajalar uchun OviTexni taqdim etadi, bu esa qo'y qorinidan olingan polipropilen, poliglikolik kislota va polilaktik-ko-glikolik kislotasi bilan mustahkamlangan to'qimalar matritsasi bo'lib, laparoskopik va robot yordamida bajariladigan churra jarrohliklarini tiklashda foydalanish uchun mo'ljallangan. Kompaniya o'z mahsulotlarini asosan Qo'shma Shtatlarda yagona to'g'ridan-to'g'ri sotish kuchlari orqali sotadi. TELA Bio, Inc. 2012 yilda tashkil etilgan va shtab-kvartirasi Malvern, Pensilvaniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Antony Koblish | Co-founder, CEO & Director |
| Mr. D. Taylor Ocasio | General Counsel & Corporate Secretary |
| Mr. Gregory A. Firestone | Chief Business Officer |
| Mr. Jeffrey Blizard | President |
| Mr. Jim Hagen | Senior VP of Strategic Commercial Operations & Marketing |
| Mr. Michael Leonard | Senior Vice President of Technical Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | 8-K | tm2614218d1_8k.htm |
| 2026-04-30 | DEF 14A | tm261452-1_def14a.htm |
| 2026-04-30 | 8-K | tm2612982d1_8k.htm |
| 2026-03-25 | S-8 | tm268780d1_s8.htm |
| 2026-03-24 | 8-K | tm269387d1_8k.htm |
| 2026-03-20 | 8-K | tm269374d1_8k.htm |
| 2025-12-12 | S-3 | tm2532716-1_s3.htm |
| 2025-11-14 | 8-K | tm2531310d1_8k.htm |
| 2025-11-03 | 8-K | tm2530000d1_8k.htm |
| 2025-10-09 | 8-K | tm2528308d1_8k.htm |
| Mr. Paul Talmo | Chief Technology Officer |
| Mr. Roberto E. Cuca J.D. | CFO, Corporate Secretary & COO |
| Ms. Jennifer Lou Armstrong | Senior Vice President of Human Resources |
| Ms. Megan Smeykal | VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer |